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IIEF Domain Scores for ITT and PP Subjects Pre-Procedure
and at 3- and 6-Month Follow-Up
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(n ¼ 27)Clariﬁcation of the Pre- and
Post-Treatment Parameter
for Erectile Dysfunction
Treatment
We read the paper by Rogers et al. (1) with great interest as it may
open up a potential new therapeutic approach for patients experi-
encing erectile dysfunction. However, we would like to have further
clariﬁcations about the data/results from the authors before we fully
appreciate the beneﬁcial role of the procedure.
The International Index of Erectile Function (IIEF) is one of the
standard tools of urologists for the assessment of erectile function
(2). The 15 questions covered 5 domains related to sexual function:
erectile function (EF), orgasmic function, sexual desire, intercourse
satisfaction, and overall satisfaction. Among these, the EF domain
is the main area assessed in studies related to the treatment
response of therapy for erectile dysfunction (2–4). Although the
primary feasibility endpoint of this study was set as an increase
of 4 points in the IIEF-6/IIEF-EF domain, the presentation of
the results appeared less clear. In the Results section, including
Table 3 (1), only IIEF, but not IIEF-6, was mentioned. Moreover,
in Figure 4 (1), only the changes in total IIEF score were shown,
but not the IIEF-6 (EF domain score). Therefore, we were
uncertain whether the 59.3% improvement of >4 points was IIEF
(total) or IIEF-6 (EF domain). Moreover, the usual practice of
presenting the results of treatment for erectile dysfunction is to
provide the pre- and post-treatment IIEF-EF domain scores for
easier reference (3,4). Unfortunately, this essential information
was not shown in the article. The only information that we
could obtain was the pre- and post-treatment total IIEF score
provided in Figure 4 (1). Because the mean improvement in total
IIEF score was only w12 points, we were not certain about the
exact contribution of the EF domain alone. Therefore, we would
greatly appreciate if the authors could provide further clariﬁcation
of the results (pre- and post-treatment IIEF-6/EF score). This
would help readers to better assess the potential role of this novel
therapy.IIEF-6 score 15.1  4.4 20.5  7.7 20.5  7.2
Mean IIEF-6 change from
baseline to follow-up for
paired subjects
5.6  7.1 5.7  6.3
PP
Pre-Procedure
(n ¼ 25)
3 Months
(n ¼ 22)
6 Months
(n ¼ 23)
IIEF-6 score 15.5  4.2 22.4  6.3 21.8  6.5
Mean IIEF-6 change from
baseline to follow-up for
paired subjects
7.1  6.3 6.5  6.5
Values are reported for subjects with available data as mean  SD.
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2883–93.ReplyWe thank Dr. Ng and colleagues for their query. As stated in the
manuscript, the primary feasibility endpoint of the ZEN trial was
obtained at 3 months and was deﬁned as improvement in erectile
function from pre-procedure of the IIEF-6 score by 4 points
in 50% of subjects. These data are presented in Table 3 in our
original article (1), which is labeled “Primary and Secondary
Endpoints.” The IIEF improvement presented in this table
represents the IIEF-6 score as described in the methods section
(although it is described as “IIEF improvement 4 points”).
Figure 4 in our original paper (1) represents the total IIEF score as
described in the ﬁgure legend. We apologize for any confusion this
may have caused. The table below provides further information not
formally presented in the article as to the raw IIEF-6 scores ob-
tained pre-procedure and in follow-up.
